Publications by authors named "Brian Behm"

Claim this Profile
F
FMT promotes type 2 mucosal immune responses with colonic epithelium proliferation in recurrent CDI patients.
G Brett Moreau, Jiayi Tian, Nick R Natale, Farha Naz, Mary K Young, Brian Behm

JCI Insight· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fulminant Clostridioides difficile Infection: A Journey into the Unknown!
Jae H Shin, Jasmine Y Jackson-Akers, Sook C Hoang, Brian W Behm, Cirle A Warren

Med Clin North Am· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avoiding Premature Antibiotic Use in Recurrent Infection After Fecal Microbiota Transplant.
Rahim A Burdette, Caroline C Whitt, Brian W Behm, Cirle A Warren

ACG Case Rep J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with failure of fecal microbiota transplant for recurrent infection.
Joseph D K Nguyen, Kibret G Yohannes, Initha Setiady, Emma C Phillips, Rachel Ann Hays, Brian W Behm

Therap Adv Gastroenterol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FMT Restores Colonic Protein Biosynthesis and Cell Proliferation in Patients with Recurrent Disease.
G Brett Moreau, Mary Young, Brian Behm, Mehmet Tanyüksel, Girija Ramakrishnan

medRxiv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic neutrophil degranulation and emergency granulopoiesis in patients with Clostridioides difficile infection.
Girija Ramakrishnan, Mary K Young, Uma Nayak, Isaura Rigo, Andrea S Marrs, Brian W Behm

Anaerobe· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clostridioides difficile infection promotes gastrointestinal dysfunction in human and mice post-acute phase of the disease.
Deiziane V S Costa, Natalie Pham, Andrea V Loureiro, Suemin E Yang, Brian W Behm

Anaerobe· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alanyl-glutamine supplementation for infection treatment (ACT): a double-blind randomised controlled trial study protocol.
Cirle A Warren, Jae Hyun Shin, Ekta N Bansal, Deiziane V D S Costa, Xin Qun Wang, Brian W Behm

BMJ Open· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P022 Biologic Therapy and Therapeutic Drug Monitoring in Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
Varun Jain, Brian Behm, Esteban Figueroa

Am J Gastroenterol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inherent Immune Cell Variation Within Colonic Segments Presents Challenges for Clinical Trial Design.
Christopher J Tyler, Mauricio Guzman, Luke R Lundborg, Shaila Yeasmin, Tamara Perez-Jeldres, Brian Behm

J Crohns Colitis· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polypharmacy is a risk factor for disease flare in adult patients with ulcerative colitis: a retrospective cohort study.
Jingzhou Wang, Takahiro I Nakamura, Anne G Tuskey, Brian W Behm

Intest Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-dose anaphylaxis to infliximab: a case of mammalian meat allergy.
Maithili Chitnavis, Daniel J Stein, Scott Commins, Alex J Schuyler, Brian Behm

J Allergy Clin Immunol Pract· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opioid use and misuse in ulcerative colitis.
Maithili V Chitnavis, Merwise Baray, Patrick G Northup, Anne G Tuskey, Brian W Behm

World J Gastrointest Pharmacol Ther· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zinc Deficiency and the Recurrence of Infection after Fecal Microbiota Transplant: A Retrospective Cohort Study.
Blake A Niccum, Daniel J Stein, Brian W Behm, R Ann Hays

J Nutr Metab· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonadherence to Biologic Therapies in Inflammatory Bowel Disease.
Brian J Wentworth, Ross C D Buerlein, Anne G Tuskey, M Ashley Overby, Mark E Smolkin, Brian W Behm

Inflamm Bowel Dis· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Type-1 Hepatorenal Syndrome with Pentoxifylline: A Randomized Placebo Controlled Clinical Trial.
Jonathan G Stine, Jennifer Wang, Scott L Cornella, Brian W Behm, Zachary Henry

Ann Hepatol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic Cholestatic Liver Injury Attributable to Vedolizumab.
Jonathan G Stine, Jennifer Wang, Brian W Behm

J Clin Transl Hepatol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor Necrosis Factor-α Therapy Is Associated With Reduced Risk of Thromboembolic Events in Hospitalized Patients With Inflammatory Bowel Disease.
Arushi M deFonseka, Anne Tuskey, Mark R Conaway, Brian W Behm

J Clin Gastroenterol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vedolizumab for induction and maintenance of remission in ulcerative colitis: a Cochrane systematic review and meta-analysis.
Mahmoud H Mosli, John K MacDonald, Stephen J Bickston, Brian W Behm, David J Tsoulis

Inflamm Bowel Dis· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Narcotic use and misuse in Crohn's disease.
Justin A Crocker, Huimin Yu, Mark Conaway, Anne G Tuskey, Brian W Behm

Inflamm Bowel Dis· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vedolizumab for induction and maintenance of remission in ulcerative colitis.
Stephen J Bickston, Brian W Behm, David J Tsoulis, Jianfeng Cheng, John K MacDonald

Cochrane Database Syst Rev· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profile of ustekinumab and its potential in patients with moderate-to-severe Crohn's disease.
Anne Tuskey, Brian W Behm

Clin Exp Gastroenterol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coil migration after transarterial coil embolization of a splenic artery pseudoaneurysm.
Bezawit D Tekola, David M Arner, Brian W Behm

Case Rep Gastroenterol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accelerated infliximab infusions for inflammatory bowel disease improve effectiveness.
John McConnell, Simona Parvulescu-Codrea, Brian Behm, Beth Hill, Elizabeth Dunkle

World J Gastrointest Pharmacol Ther· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dexlansoprazole MR for the management of gastroesophageal reflux disease.
Brian W Behm, David A Peura

Expert Rev Gastroenterol Hepatol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis